Back
Akero Therapeutics Vs. Aldeyra Therapeutics Industry Stock Comparison
Sell
40
AKRO
Akero Therapeutics
Last Price:
21.98
Seasonality Move:
56.48%
Sell
34
ALDX
Aldeyra Therapeutics
Last Price:
3.19
Seasonality Move:
18.79%
Sell
40
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $21.93. The Score for AKRO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Aldeyra Therapeutics (ALDX)
is a Sell
Is Aldeyra Therapeutics a Buy, Sell or Hold?
- The current Aldeyra Therapeutics [ALDX] share price is $3.20. The Score for ALDX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- ALDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $21.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight selling pressure.
ALDX Stock Price Chart
What is Aldeyra Therapeutics's stock price today?
-
The Aldeyra Therapeutics share price today is $3.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALDX is experiencing slight selling pressure.
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 47.63 | Sell |
| Chaikin Money Flow: | -89866 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.26 - 24) | Sell |
| Bollinger Bands (100): | (19.84 - 25.98) | Sell |
ALDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 34.64 | Sell |
| Chaikin Money Flow: | -54858 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.34 - 3.92) | Sell |
| Bollinger Bands (100): | (3.26 - 4.14) | Sell |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.08 | Sell |
| 20-day SMA: | 22.96 | Sell |
| 50-day SMA: | 21.16 | Buy |
| 200-day SMA: | 23.03 | Sell |
| 8-day EMA: | 22.77 | Sell |
| 20-day EMA: | 22.51 | Sell |
| 50-day EMA: | 22.06 | Sell |
| 200-day EMA: | 25.22 | Sell |
ALDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.29 | Sell |
| 20-day SMA: | 3.58 | Sell |
| 50-day SMA: | 3.81 | Sell |
| 200-day SMA: | 3.57 | Sell |
| 8-day EMA: | 3.31 | Sell |
| 20-day EMA: | 3.5 | Sell |
| 50-day EMA: | 3.67 | Sell |
| 200-day EMA: | 4.18 | Sell |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.95 per share, and a decrease next year of $0.54 per share.
Aldeyra Therapeutics Earnings Growth & ALDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.49 per share, and a decrease next year of $0.23 per share.
Akero Therapeutics Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aldeyra Therapeutics Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||